Volgen
Lizz van der Heijden MD PhD MA
Lizz van der Heijden MD PhD MA
Orthopedic Surgery, Leiden University Medical Center, Leiden, the Netherlands
Geverifieerd e-mailadres voor lumc.nl
Titel
Geciteerd door
Geciteerd door
Jaar
The clinical approach toward giant cell tumor of bone
L Van der Heijden, PDS Dijkstra, MAJ van de Sande, JR Kroep, RA Nout, ...
The oncologist 19 (5), 550-561, 2014
2742014
Giant cell tumour of bone in the denosumab era
L van der Heijden, PDS Dijkstra, JY Blay, H Gelderblom
European Journal of Cancer 77, 75-83, 2017
1502017
Giant cell tumor with pathologic fracture: should we curette or resect?
L van der Heijden, PDS Dijkstra, DA Campanacci, CLMH Gibbons, ...
Clinical Orthopaedics and Related Research® 471 (3), 820-829, 2013
1142013
The management of diffuse-type giant cell tumour (pigmented villonodular synovitis) and giant cell tumour of tendon sheath (nodular tenosynovitis)
L Van der Heijden, C Gibbons, PDS Dijkstra, JR Kroep, CSP Van Rijswijk, ...
The Journal of Bone & Joint Surgery British Volume 94 (7), 882-888, 2012
932012
A multidisciplinary approach to giant cell tumors of tendon sheath and synovium—a critical appraisal of literature and treatment proposal
L van der Heijden, CLMH Gibbons, AB Hassan, JR Kroep, H Gelderblom, ...
Journal of surgical oncology 107 (4), 433-445, 2013
762013
Soft tissue extension increases the risk of local recurrence after curettage with adjuvants for giant-cell tumor of the long bones: a retrospective study of 93 patients
L van der Heijden, MA Van de Sande, PD Dijkstra
Acta Orthopaedica 83 (4), 401-405, 2012
662012
Liquid nitrogen or phenolization for giant cell tumor of bone?: a comparative cohort study of various standard treatments at two tertiary referral centers
L van der Heijden, ICM van der Geest, HWB Schreuder, ...
JBJS 96 (5), e35, 2014
632014
Functional outcome and quality of life after the surgical treatment for diffuse-type giant-cell tumour around the knee: a retrospective analysis of 30 patients
L Van der Heijden, MJL Mastboom, PDS Dijkstra, MAJ van de Sande
The bone & joint journal 96 (8), 1111-1118, 2014
612014
Mid-term outcome after curettage with polymethylmethacrylate for giant cell tumor around the knee: higher risk of radiographic osteoarthritis?
L van der Heijden, MAJ van de Sande, AC Heineken, M Fiocco, ...
JBJS 95 (21), e159, 2013
612013
Pigmented villonodular synovitis: a crowdsourcing study of two hundred and seventy two patients
L van der Heijden, SR Piner, MAJ van de Sande
International orthopaedics 40, 2459-2468, 2016
422016
Giant cell tumours of the small bones of the hands and feet: long-term results of 30 patients and a systematic literature review
VC Oliveira, L Van der Heijden, ICM Van Der Geest, DA Campanacci, ...
The bone & joint journal 95 (6), 838-845, 2013
422013
Current concepts in the treatment of giant cell tumour of bone
L van der Heijden, S Dijkstra, M van de Sande, H Gelderblom
Current opinion in oncology 32 (4), 332-338, 2020
342020
Giant cell tumors of the sacrum—a nationwide study on midterm results in 26 patients after intralesional excision
L Van der Heijden, MAJ van de Sande, ICM van der Geest, ...
European Spine Journal 23, 1949-1962, 2014
302014
Adjuvant zoledronic acid in high‐risk giant cell tumor of bone: a multicenter randomized phase II trial
A Lipplaa, JR Kroep, L van der Heijden, PC Jutte, PCW Hogendoorn, ...
The oncologist 24 (7), 889-e421, 2019
242019
Neoadjuvant denosumab for extensive giant cell tumor in os ischium—a case report
L Heijden, MAJ Sande, PCW Hogendoorn, H Gelderblom, PDS Dijkstra
Acta Orthopaedica 86 (3), 393-395, 2015
192015
Updated concepts in treatment of giant cell tumor of bone
L van der Heijden, A Lipplaa, K van Langevelde, JVMG Bovée, ...
Current opinion in oncology 34 (4), 371-378, 2022
182022
Management of tenosynovial giant cell tumour of the foot and ankle
G Spierenburg, ST Lancaster, L van der Heijden, MJL Mastboom, ...
The Bone & Joint Journal 103 (4), 788-794, 2021
142021
Tenosynovial giant cell tumors (TGCT): molecular biology, drug targets and non-surgical pharmacological approaches
G Spierenburg, L van der Heijden, K van Langevelde, K Szuhai, ...
Expert Opinion on Therapeutic Targets 26 (4), 333-345, 2022
102022
Surgical management of 144 diffuse‐type TGCT patients in a single institution: A 20‐year cohort study
G Spierenburg, L van der Heijden, MJL Mastboom, K van Langevelde, ...
Journal of Surgical Oncology 126 (6), 1087-1095, 2022
92022
Long-term follow-up of nilotinib in patients with advanced tenosynovial giant cell tumours: Long-term follow-up of nilotinib in TGCT
G Spierenburg, P Grimison, C Chevreau, S Stacchiotti, ...
European Journal of Cancer 173, 219-228, 2022
82022
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20